Mesmerize expands reach in pharmacy and grocery locations with Higi partnership
Mesmerize has announced a new partnership with Higi, a Modivcare service and consumer health engagement company.
Pharmacy
NIH study finds high rates of persistent chronic pain among U.S. adults
A study from the National Institutes of Health shows that new cases of chronic pain occur more often among U.S. adults than new cases of several other common conditions, including diabetes, depression, and high blood pressure.
NACDS Foundation sponsors 41st Annual March of Dimes Gourmet Gala
On Wednesday, May 10, March of Dimes hosted its 41st Annual March of Dimes Gourmet Gala in Washington, DC, and the National Association of Chain Drug Stores Foundation (NACDS Foundation) returned — for the seventh year — as a Platinum Sponsor of the event.
MakoRx launches Care Connect in local pharmacies across North Carolina
MakoRx, a pioneer in providing innovative healthcare solutions, is excited to announce the expansion of its groundbreaking program, Care Connect, to local pharmacies across North Carolina.
McKesson unveils Pinpoint Community Solutions Inventory Management System
McKesson announced the launch of Pinpoint Community Solutions, an intelligent perpetual inventory management system powered by Supplylogix.
APC makes statement on shortage-drug compounding and semaglutide
The Alliance for Pharmacy Compounding, the national trade association representing the pharmacy compounding profession, has released an extensive statement on compounding copies of FDA approved drugs when those drugs are in shortage. The statement focuses in particular on semaglutide.
Diabetes study shows health apps help patients reduce blood sugar
Researchers from the Organization for the Review of Care and Health Apps (ORCHA) have found that blood glucose levels among those with Type 2 Diabetes can be reduced by up to 1.1% when patients use digital health tools alongside their standard medication.
Aurobindo gets FDA nod for nitrofurantoin oral suspension
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application nitrofurantoin oral suspension USP, 25 mg/5 mL.
Aurobindo receives FDA approval for phenoxybenzamine hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application phenoxybenzamine hydrochloride capsules 10mg.
PQA presents Quality Awards to eight Medicare plan contracts
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has recognized eight Medicare plan contracts with a PQA Laura Cranston Excellence in Quality or Quality Improvement Award for high achievement or significant improvement in PQA measures of medication safety and appropriate use.
PCMA makes statement on HELP Committee vote on S. 1339
The Pharmaceutical Care Management Association (PCMA) released the following statement today on the legislative markup on S. 1339, the Pharmacy Benefit Manager Reform Act, by the U.S. Health, Education, Labor & Pensions (HELP) Committee.
HDA issues statement on expiration of the COVID-19 public health emergency
The Healthcare Distribution Alliance (HDA) released a statement from president and CEO Chester “Chip” Davis, Jr.
National Coalition urges Congress to enact H.R. 1770
WASHINGTON – The Future of Pharmacy Care Coalition, a group representing pharmacists and community pharmacies of all sizes serving millions of patients across the U.S.
CVS to offer free, community-based mental health screenings
CVS Health announced Wednesday it is enhancing Project Health, the company’s free, community-based health screening program by adding mental health screenings to its services and entering two new areas: Greensboro, N.C. and Petersburg, Va.
Aetna donates $250,000 to support health and wellbeing of children in Virginia
Aetna Better Health of Virginia, a CVS Health company, announced that Aetna has made donations totaling $250,000 to three local community partners focused on improving the health and wellbeing of people in under-resourced areas.
Former CDC official and NACDS: States should continue “PREP Act” Rx access
Recently announced federal action provides states a “reasonable timeline” to prevent disruption of the pharmacy access relied upon and expected by patients during the COVID-19 pandemic and beyond, according to an article published today in Health Security, a Johns Hopkins University peer-reviewed jo